REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,761,000 | +24.5% | 17,500 | +75.0% | 0.62% | +9.9% |
| Q2 2021 | $1,415,000 | +1.4% | 10,000 | -28.6% | 0.56% | +12.3% |
| Q1 2021 | $1,396,000 | -41.5% | 14,000 | -8.5% | 0.50% | -27.1% |
| Q2 2020 | $2,387,000 | -29.6% | 15,300 | -34.9% | 0.69% | -58.0% |
| Q1 2020 | $3,392,000 | -56.3% | 23,500 | -38.2% | 1.64% | -14.6% |
| Q4 2019 | $7,768,000 | +115.0% | 38,000 | -15.6% | 1.92% | -26.2% |
| Q3 2019 | $3,613,000 | – | 45,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |